Ospedale Pediatrico Bambino Gesu
Ospedale Pediatrico Bambino Gesu is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 - A Randomized Phase III Study Conducted by the Resistant Disease Committee of the International BFM Study Group - IntReALL BCP 2020
Sponsor Charite Universitaetsmedizin Berlin KöR
- Start (EU)
- Not reported
- Latest update
- Estimated end
An Open-label, Sequential, Ascending, Repeated Dose-finding Study of Sarilumab, Administered with Subcutaneous (SC) Injection, in Children and Adolescents, Aged 1 to 17 Years, with Systemic Juvenile Idiopathic Arthritis (sJIA), Followed by an Extension Phase. Name: SKYPS
Sponsor Sanofi-Aventis Recherche & Developpement
- Start (EU)
- Latest update
- Estimated end
ICC APL STUDY 02 Treatment study for children and adolescents with Acute Promyelocytic Leukemia
Sponsor Associazione Italiana Ematologia Oncologia Pediatrica
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Ospedale Pediatrico Bambino Gesu?
The 2026-10-09 snapshot links Ospedale Pediatrico Bambino Gesu to 3 distinct CTIS trials. Recorded services include Medical expertise, Clinical monitoring, Data management, Investigator recruitment, among 11 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Ospedale Pediatrico Bambino Gesu?
The most frequently recorded therapeutic areas are Haematological Malignancies, Immunology, Rheumatology. Recorded phases include Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Ospedale Pediatrico Bambino Gesu conducted?
The linked trials record locations in 18 countries, including France, Italy, Czechia, Germany, Spain. These are trial locations, not confirmed office locations or countries where Ospedale Pediatrico Bambino Gesu delivered services.
What can this page tell me about Ospedale Pediatrico Bambino Gesu's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Ospedale Pediatrico Bambino Gesu. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Ospedale Pediatrico Bambino Gesu